Navigation Links
VWR to Hold First Quarter 2012 Financial Results Conference Call
Date:5/7/2012

RADNOR, Pa., May 7, 2012 /PRNewswire/ -- VWR Funding, Inc., the parent company of VWR International, LLC, a leading global laboratory supply and distribution company, will hold a conference call on Thursday, May 10, 2012, to discuss its first quarter 2012 financial results. Who:John M. Ballbach, Chairman, President and CEOGregory L. Cowan, Senior Vice President and CFOWhen:Thursday, May 10, 20129:00 AM Eastern Time (ET)How: 

 

 

Interested parties may participate by dialing (760) 298-5093 or toll free at (877) 845-1003. A replay of the call will be available on Thursday, May 10, 2012 at 12:00 PM ET through Thursday, May 24, 2012 at midnight, by dialing (404) 537-3406 or toll free at (800) 585-8367, pass code for both replay numbers will be 76187966.Information: 

 VWR Funding's Quarterly Report on Form 10-Q for the quarter ended March 31, 2012, will be filed on or before Thursday, May 10, 2012, with the Securities and Exchange Commission.About VWR International, LLC VWR International, LLC, headquartered in Radnor, Pennsylvania, is a global laboratory supply and distribution company with worldwide sales in excess of $4.1 billion in 2011. VWR enables the advancement of the world's most critical research through the distribution of a highly diversified product line to most of the world's top pharmaceutical and biotech companies, as well as industrial, educational and governmental organizations. With 150 years of industry experience, VWR offers a well-established distribution network that reaches thousands of specialized labs and facilities spanning the globe. VWR has over 8,000 associates around the world working to streamline the way researchers across North America, Europe, and Asia stock and maintain their labs. In addition, VWR further supports its customers by providing onsite services, storeroom management, product procurement, supply chain systems integration and technical services.

For more information on VWR, phone 1-800-932-5000, visit www.vwr.com, or write, VWR, Radnor Corporate Center, Building One, Suite 200, 100 Matsonford Road, Radnor, PA 19087.

VWR and design are registered trademarks of VWR International, LLC.


'/>"/>
SOURCE VWR Funding, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. China Pharma Holdings, Inc. to Report First Quarter of Fiscal Year 2012 Financial Results on May 15, 2012
2. PDL BioPharma Announces First Quarter 2012 Financial Results
3. Verenium Corporation To Announce First Quarter 2012 Financial Results
4. Discovery Labs Reports First Quarter 2012 Financial Results
5. Sangamo BioSciences Reports First Quarter 2012 Financial Results
6. MiMedx Group Announces Record First Quarter Results
7. Innophos Holdings, Inc. Reports First Quarter 2012 Results
8. Sangamo BioSciences Announces First Quarter 2012 Conference Call and Webcast
9. Dyadic International To Release First Quarter 2012 Financial Results And Host Conference Call
10. First atomic-scale real-time movies of platinum nanocrystal growth in liquids
11. Cell Therapeutics, Inc. (CTI) Reports First Quarter Financial Results and Milestones
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... 28, 2017 Dr. Chris Yu ... corporation Anpac Bio-Medical Science Company , announced ... record, processing and reporting over 40,000 cases worldwide ... (CDA) liquid biopsy tests. Described ... Summit publications, Anpac Bio,s CDA medical devices and ...
(Date:3/28/2017)... ... March 28, 2017 , ... Currently symptomatic therapies for Parkinson’s ... study published in STEM CELLS suggests that human neural stem cell (hNSC) transplantation ... produce more neural cells. , Strategies involving transplantation of these cells into ...
(Date:3/28/2017)... 2017 /PRNewswire/ -RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSXV: RP) ... safety and clinical data from its phase 1/2 tendon repair ... follicle-derived fibroblasts (RCT-01) as a treatment for Achilles tendinosis. ... The ... profile at 6 months and showed no serious adverse events ...
(Date:3/27/2017)... , March 27, 2017 Roka Bioscience, Inc. (NASDAQ: ... solutions for the detection of foodborne pathogens,  today announced that ... & Company Spring 2017 Convention on March 29 at 9:50am ... Marriott Marquis. About Roka Bioscience ... Roka Bioscience ...
Breaking Biology Technology:
(Date:3/6/2017)... MATEO, Calif. , March 6, 2017 /PRNewswire/ ... marketing and sales technology, today announced Predictive Sales ... solution for infusing actionable sales intelligence into Salesforce. ... to automatically enable their sales organizations with deep ... messages that allow for intelligent engagement. Predictive Sales ...
(Date:3/2/2017)... MELBOURNE, Australia , March 2, 2017 ... Therapeutics Ltd (ASX: CYP), has signed an agreement ... researchers from the Monash Biomedicine Discovery Institute and Department ... , to conduct a further preclinical study to support ... the treatment of asthma.  Asthma is ...
(Date:2/28/2017)... Spanien, 27. Februar 2017  EyeLock LLC, ein marktführendes ... seine erstklassige biometrische Lösung zur Iris-Erkennung auf ... X16 LTE auf dem Mobile World Congress ... Qualcomm-Stand in Halle 3, Stand 3E10, vorstellen. ... Sicherheitsplattform Qualcomm Haven™ – eine Kombination aus ...
Breaking Biology News(10 mins):